In xenograft breast tumors, MTF treatment of mice resulted in decreased levels of platelet and endothelial cell adhesion molecule 1 (PECAM1; alias, CD31) which was used as an endothelial cell marker to examine changes of vascular branches [77]. Here, PECAM1 is linked to breast neoplasm.